A randomized clinical trial in breast cancer care has found that digital monitoring of patient-reported outcomes was associated with clinically meaningful reductions in fatigue and improvements in physical functioning. The findings add to growing evidence that routine symptom tracking through digital tools may help oncology teams identify problems earlier and respond before they substantially disrupt patients’ daily lives.
Unlike conventional clinical assessments, which often depend on appointments and brief conversations, patient-reported outcome monitoring allows people to report symptoms directly and repeatedly from home. Participants can describe fatigue, physical limitations, pain, emotional distress, and other aspects of health through electronic questionnaires. These data can then be reviewed by care teams, creating a more continuous picture of how patients are coping between visits.
The trial focused on an alert-based approach. In this model, a patient’s responses are evaluated against predefined thresholds or clinically relevant changes. When a concerning pattern is detected, the system can generate an alert for oncology staff. The purpose is not simply to collect information, but to connect reported symptoms with timely clinical attention, supportive care, medication adjustments, or further evaluation.
Fatigue is one of the most common and persistent difficulties experienced by people receiving cancer treatment. It can arise from the disease itself, chemotherapy, radiation, endocrine therapy, anemia, sleep disruption, psychological stress, or several factors acting together. Because fatigue may fluctuate and is not always visible during a consultation, it can be underestimated unless patients are asked about it systematically.
Physical functioning is similarly important but can be difficult to assess using isolated clinical measurements. A patient may appear stable in a clinic while struggling to climb stairs, prepare meals, work, exercise, or manage household responsibilities. Digital questionnaires offer a way to capture these everyday limitations in the patient’s own words and on a timeline that reflects real-life changes rather than a single appointment.
The investigators reported that digital patient-reported outcome monitoring was linked to improvements in both fatigue and physical functioning that reached a level considered clinically meaningful. That distinction is important. A statistically significant difference does not always translate into an improvement that patients can feel in their daily lives, whereas a clinically meaningful change suggests that the benefit may have practical relevance for functioning and well-being.
The results support a broader shift in oncology toward incorporating patients’ experiences into treatment decisions. Traditionally, cancer care has relied heavily on laboratory values, imaging, physical examinations, and clinician assessments. Those measures remain essential, but they do not fully describe symptoms that affect quality of life. Patient-reported data can complement biomedical information by showing how treatment is experienced outside the clinic.
Alert-based monitoring may also help address a persistent challenge in cancer care: the gap between the onset of symptoms and clinical intervention. Patients may delay reporting problems because they are unsure whether symptoms are serious, do not want to interrupt treatment, or assume that side effects are unavoidable. A structured digital system can lower that barrier by prompting regular reporting and signaling when follow-up may be warranted.
However, the findings do not mean that digital monitoring alone can solve every problem in oncology. Its effectiveness depends on reliable access to digital devices, clear communication, staff capacity to review alerts, and well-designed protocols for responding to them. If alerts are too frequent, clinicians may experience alarm fatigue; if thresholds are too insensitive, important deterioration may go unnoticed. Successful implementation therefore requires both technical precision and clinical judgment.
The study’s authors argue that these results justify further evaluation of alert-based patient-reported outcome monitoring in routine oncology care. Future research will need to determine which symptoms should trigger alerts, how quickly teams should respond, and whether improvements in fatigue and physical functioning lead to better treatment completion, fewer emergency visits, improved survival, or lower health care costs. The findings nevertheless point toward a model of cancer care in which patients’ day-to-day experiences become an active, continuously monitored part of clinical decision-making.
Subject of Research: Digital patient-reported outcome monitoring in breast cancer oncology care
Web References: JAMA Oncology, DOI: https://doi.org/10.1001/jamaoncol.2026.2661; JAMA+ AI: https://jamanetwork.com/channels/ai/pages/about
References: Maria Margarete Karsten, Department of Gynecology with Breast Center, Charité–Universitätsmedizin Berlin; randomized clinical trial published in JAMA Oncology
Keywords: Breast cancer, oncology, patient monitoring, health care, randomization, clinical trials, electronic devices, communications
Tags: alert-based clinical trialClinical Decision Support Systemscontinuous health monitoring in cancer caredigital health tools for cancer patientsdigital patient-reported outcomesearly detection of treatment side effectselectronic patient questionnairesfatigue management in breast cancerimproving quality of life through digital monitoringmetastatic breast cancer symptom monitoringpatient engagement in symptom reportingremote symptom tracking in oncology
